Replies to post #596 on Galectin Therapeutics Inc. (GALT)

[Darwinian]

Thanks.
LOL,
That IS a hugely important distinction. I guess I was mentally lumping several fibrosis diseases together. Makes sense to nail down the big money-maker or "greatest need" first, I suppose (if it is, in fact, kidney disease is huge too)

So, if I may ask another question (or if you don't mind answering)...

In discussing call options, I'm thinking of buying a few for October as that would allow even more time to verify the efficacy of the treatment and by then phase 2 will likely have started if not possibly have reports available. It would also allow time to raise extra funds to pay for the shares. Does this approach make sense? Or, am I missing something about how options work that make this a less appealing idea? I need to lay off the GALT buying for a little while. There are a couple of other stocks that I'd like to get into before the price gets too high. Though, I may buy 25 more shares to make an even 500 (probably weird but I like neat numbers).

I'm really looking forward to seeing where this all goes in the next year or so. However, I do reserve the right to change my tune at any time ;)

Thanks much.